Mesoblast (MESO) EBITDA Margin Growth (3y) (2017 - 2023)
Mesoblast (MESO) EBITDA Margin Growth (3y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 78,837.00 |
| Mar 31, 2023 | 49,452.00 |
| Dec 31, 2022 | 53,081.00 |
| Sep 30, 2022 | -35,319.00 |
| Jun 30, 2022 | 139,358.00 |
| Mar 31, 2022 | 188,873.00 |
| Dec 31, 2021 | 157,323.00 |
| Sep 30, 2021 | 132,126.00 |
| Jun 30, 2021 | 65,674.00 |
| Mar 31, 2021 | 136,384.00 |
| Dec 31, 2020 | -80,155.00 |
| Sep 30, 2020 | -79,089.00 |
| Jun 30, 2020 | 547,996.00 |
| Mar 31, 2020 | 92,147.00 |
| Dec 31, 2019 | 384,571.00 |
| Sep 30, 2019 | 575,504.00 |
| Jun 30, 2019 | -127,123.00 |
| Mar 31, 2019 | -169,294.00 |
| Dec 31, 2018 | -181,219.00 |
| Sep 30, 2018 | -167,239.00 |